Showing results (3451-3460 of 4,142) with videos related to
Sort By:
Pageof 415
Molecular Carcinogenesis|December 19, 2002
Mechanism of action of a dominant negative c-jun mutant in inhibiting activator protein-1 activationEric J Thompson, Ashok Gupta, M Suzanne Stratton, et al.Molecular Carcinogenesis|December 19, 2002
Expression, localization, and activity of glycogen synthase kinase 3beta during mouse skin tumorigenesisHugo Leis, Carmen Segrelles, Sergio Ruiz, et al.Molecular Carcinogenesis|April 2, 2003
Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGF beta 1Osamu Hashimoto, Takato Ueno, Rina Kimura, et al.Molecular Carcinogenesis|April 2, 2003
Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational 'hotspots' and the relative expression of beta-catenin and c-junCarmen A Blum, Tomoko Tanaka, Xiaoying Zhong, et al.Molecular Carcinogenesis|September 2, 2003
Involvement of the Akt/mTOR pathway on EGF-induced cell transformationMasaaki Nomura, Zhiwei He, Ichiko Koyama, et al.Molecular Carcinogenesis|January 1, 1992
Efficient protection against oxidative DNA damage in chromatinM Ljungman, P C HanawaltMolecular Carcinogenesis|January 1, 1992
Alternative splicing of neurofibromatosis type 1 gene transcript in malignant brain tumors: PCR analysis of frozen-section mRNAH Mochizuki, T Nishi, J M Bruner, et al.Molecular Carcinogenesis|January 1, 1992
Kinds of mutations induced by aflatoxin B1 in a shuttle vector replicating in human cells transiently expressing cytochrome P4501A2 cDNAY Trottier, W I Waithe, A AndersonMolecular Carcinogenesis|November 26, 2003
Suppression of the transformed phenotype and induction of differentiation-like characteristics in cultured ovarian tumor cells by chronic treatment with progesteroneMartina Blumenthal, Adel Kardosh, Louis Dubeau, et al.Molecular Carcinogenesis|November 26, 2003
EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancerGiuseppe Giannini, Maria Irene Ambrosini, Lucia Di Marcotullio, et al.Pageof 415